Boceprevir for Untreated Chronic HCV Genotype 1 Infection

BACKGROUND: Peginterferon–ribavirin therapy is the current standard of care for chronic infection with hepatitis C virus (HCV). The rate of sustained virologic response has been below 50% in cases of HCV genotype 1 infection. Boceprevir, a potent oral HCV-protease inhibitor, has been evaluated as an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Poordad, Fred, McCone, Jonathan, Bacon, Bruce R., Bruno, Savino, Manns, Michael P., Sulkowski, Mark S., Jacobson, Ira M., Reddy, K. Rajender, Goodman, Zachary D., Boparai, Navdeep, DiNubile, Mark J., Sniukiene, Vilma, Brass, Clifford A., Albrecht, Janice K., Bronowicki, Jean-Pierre
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3766849/
https://ncbi.nlm.nih.gov/pubmed/21449783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1010494
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados